It is understood that the intention of cooperation between Zero Krypton and Merck & Co Inc China means that in the future, the two sides will give full play to their respective advantages in the fields of medicine and health and Internet medical care, and jointly explore Internet + Medical and Health in China. LinkDoc Technology, a cancer-focused medical data company, has filed paperwork for a 100m offering of American depository shares (ADS). (hereinafter referred to as 'Merck & Co Inc China') officially signed a memorandum of cooperation, demonstrating their intention to explore innovative ways of cooperation in the fields of patient health management, digital technology and digital pharmaceutical industry, so as to help the implementation of the 'healthy China' strategy. (hereinafter referred to as 'Zero Krypton Technology' or 'Zero Krypton') and Merck & Co Inc (China) Investment Co., Ltd. Pre IPO 12 - 18 months 6 months Years Kick-off meeting IPO Pricing IPO Post IPO Assessment Readiness Planning and preparation Going Public Execution of the IPO. November 8, Zero Krypton Technology (Tianjin) Co., Ltd. In our experience, businesses that have undertaken a full pre-IPO readiness exercise are those that are best prepared to handle the complexities of an IPO. Our base case valuation of LinkDoc Technology suggests an implied market cap of 2.0 billion or 22. Zero Krypton Technology and Merck & Co Inc China have reached a cooperation to explore a new path of digital cooperation in the pharmaceutical industry. Webull offers kinds of LINKDOC TECHNOLOGY LTD stock information, including NASDAQ:LDOC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LDOC stock news, and many more online research tools to help you make informed decisions. IPO Plansīenzinga Real-time News 04-11-2022 07:30:37 LinkDoc, which is backed by Alibaba Health Information Technology, is also mulling a fresh initial public offering (IPO) in Hong Kong instead of across the. LinkDoc Technology Filed to Withdraw U.S. Provide the latest market data of LinkDoc Technology (LDOC), including prices, candlestick charts of various timeframes, basic information and real-time. Reducing the marketing burden first is the right path. How To Buy LinkDoc Technology Limited IPO Stock (LDOC) LDOC LinkDoc Technology Ltd ADR Share Price - NG LINKDOC TECHNOLOGY LIMITED : LDOC. auditing rules.After reading the financial reports of more than 10 medical companies, are these the only 3 that can make money? LinkDoc Technology Readies 200 Million U.S. regulations being rolled out that could see Chinese companies delisted if they do not comply with U.S. A high-level overview of LinkDoc Technology Limited (LDOC) stock. LinkDoc Technology, a Chinese healthcare data company specializing in oncology patients, filed on Monday with the SEC to raise up to 100 million in an initial public offering. read moreĪnalysts also note the tougher stance coincides with new U.S. LinkDoc Technology, which is a China-based company that leverages sophisticated data technologies for oncology patients, was expected to pull off its IPO last week. regulators will potentially gain more access to audit documents of New York-listed Chinese companies.

The company, which is reportedly backed by Alibaba, filed for an IPO last month and was due to set a price for its shares later today (Thursday July 8). HONG KONG (Reuters) Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States following Beijings clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter. listing plans and opt for Hong Kong instead, with one source at the time citing Beijing's concerns that U.S. LinkDoc Technology Ltd has suddenly shelved an IPO that was set to raise up to 211 million in the US, according to sources who spoke to Reuters and Nikkei. In May, Reuters reported that Beijing was pressing audio platform Ximalaya to drop U.S. The tougher stance by the Cybersecurity Administration of China has been driven in part by concerns that the United States could gain greater access to data owned by Chinese firms - similar to concerns that the previous Trump administration had voiced about Chinese firms operating in the United States. later this year, a review of the filings showed. listings, Refinitiv data shows, well up from the $1.9 billion from 14 deals in the same period a year ago.Įight Chinese companies including home service platform Daojia Ltd and Atour Lifestyle Holdings have made public filings with the Securities and Exchange Commission (SEC) to list in the U.S. So far this year, a record $12.5 billion by Chinese firms has been raised from 34 U.S.

Linkdoc technology ipo